Thyssenkrupp-Tata Steel remedies won't impact JV synergies - source

Reuters

Published Apr 02, 2019 11:45

Thyssenkrupp-Tata Steel remedies won't impact JV synergies - source

FRANKFURT/DUESSELDORF, Germany (Reuters) - Asset sales offered by Thyssenkrupp (DE:TKAG) and Tata Steel to get antitrust approval for a planned joint venture will not jeopardise targeted synergies for the combined entity, a person familiar with the matter said.

The two steelmakers submitted a remedy proposal to the European Commission late on Monday, offering remedies including selling two hot-dip galvanising plants in Spain and Belgium that supply the automotive industry.

Along with packaging and electrical steel, that had been one of the areas of competitive concern for the Commission, which now has until June 5 to review the offer and make a decision.

The joint venture, which was signed last year but still needs to be approved by the European Commission, targets 400 million (343.41 million pounds) to 500 million euros in annual synergies.

Remedies also include the potential sale of packaging steel activities operated by Tata Steel in Britain and Belgium, the source said, adding the Commission had dropped its concerns in the area of electrical steel.

Thyssenkrupp declined to comment on the specific proposals.